SOBYCOMBI tablett Eesti - eesti - Ravimiamet

sobycombi tablett

krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 5mg+10mg 28tk; 5mg+10mg 84tk; 5mg+10mg 56tk; 5mg+10mg 90tk; 5mg+10mg 60tk

SOBYCOMBI tablett Eesti - eesti - Ravimiamet

sobycombi tablett

krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 10mg+5mg 56tk; 10mg+5mg 84tk

SOBYCOMBI tablett Eesti - eesti - Ravimiamet

sobycombi tablett

krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 5mg+5mg 30tk; 5mg+5mg 84tk; 5mg+5mg 56tk; 5mg+5mg 90tk; 5mg+5mg 28tk; 5mg+5mg 60tk

SOBYCOMBI tablett Eesti - eesti - Ravimiamet

sobycombi tablett

krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 10mg+10mg 60tk; 10mg+10mg 90tk; 10mg+10mg 30tk; 10mg+10mg 28tk; 10mg+10mg 56tk

CANDISIL HCT tablett Eesti - eesti - Ravimiamet

candisil hct tablett

laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 16mg+12,5mg 56tk; 16mg+12,5mg 100tk; 16mg+12,5mg 14tk; 16mg+12,5mg 300tk; 16mg+12,5mg 7tk; 16mg+12,5mg 15tk

CANDISIL HCT tablett Eesti - eesti - Ravimiamet

candisil hct tablett

laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 8mg+12,5mg 30tk; 8mg+12,5mg 100tk; 8mg+12,5mg 56tk; 8mg+12,5mg 98tk

CANDISIL HCT tablett Eesti - eesti - Ravimiamet

candisil hct tablett

laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 32mg+12,5mg 28tk; 32mg+12,5mg 56tk; 32mg+12,5mg 50tk; 32mg+12,5mg 15tk; 32mg+12,5mg 100tk

CANDISIL HCT tablett Eesti - eesti - Ravimiamet

candisil hct tablett

laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 32mg+25mg 7tk; 32mg+25mg 300tk; 32mg+25mg 100tk; 32mg+25mg 15tk; 32mg+25mg 56tk; 32mg+25mg 98tk

Elonva Euroopa Liit - eesti - EMA (European Medicines Agency)

elonva

n.v. organon - korifollitropiin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - suguhormoonid ja genitaalsüsteemi, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

Trimbow Euroopa Liit - eesti - EMA (European Medicines Agency)

trimbow

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol dietüülfumaraat dihüdraat, glycopyrronium bromiid - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.